Zai Lab Ltd (23) | Business Operations (5)

Browse by Subcategory

Collaboration Agreements (5)

Recent Contracts

License and Collaboration Agreement by and between Zai Lab (Shanghai) Co., Ltd. and Blueprint Medicines Corporation, dated November 8, 2021 (Filed With SEC on March 1, 2022)
Collaboration and License Agreement, dated as of May 28, 2021, by and between Zai Lab (Hong Kong) Limited and Mirati Therapeutics, Inc (Filed With SEC on August 9, 2021)
License and Collaboration Agreement, dated as of June 15, 2021, by and between Zai Lab (US) LLC and MacroGenics, Inc (Filed With SEC on August 9, 2021)
Collaboration and License Agreement between argenx BV and Zai Auto Immune (Hong Kong) Limited dated January 6, 2021 (Filed With SEC on May 10, 2021)
Collaboration Agreement between Regeneron Ireland Designated Activity Company and Zai Lab (Shanghai) Co., Ltd. dated April 6, 2020 (Filed With SEC on March 1, 2021)